Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
National Patient Safety Alert: Class 1 Medicines Recall for Co-codamol 30/500 effervescent tablets (Zentiva)
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Co-codamol 30/500 Effervescent Tablets (Zentiva Pharma UK Ltd) Co-codamol 30/500 Effervescent Tablets PL 17780/0046 NatPSA/2021/004/MHRA Date issued: 16 June 2021 Zentiva Pharma UK Limited is recalling the below batch of Co-codamol 30/500 Effervescent Tablets as a precautionary measure due to an issue with the...
Last call for contractors to complete the HEE workforce survey
Community pharmacy contractors have until 11.59pm this Friday (18th June) to complete the 2021 Health Education England (HEE) Community Pharmacy Workforce Survey.* PSNC encourages all contractors to participate in this voluntary survey, as the results will help inform the future planning and funding in relation to the development of the community pharmacy workforce across the...
Flu vac: confirmation of training requirements for 2021/22
Community pharmacy contractors are required to demonstrate that all pharmacists providing the flu vaccination service in their pharmacy have the skills needed to do so. NHS England and NHS Improvement (NHSE&I), working with Public Health England, has confirmed to PSNC that the normal training requirements for pharmacists providing the service are being reinstated for the...
Medicine Supply Notification: Fluoxetine (Olena) 20mg dispersible sugar free tablets
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Fluoxetine (Olena) 20mg dispersible sugar free tablets MSN/2021/029 Tier 2 – medium impact Date of issue: 14/06/2021 Fluoxetine 20mg dispersible sugar free tablets are out of stock until the end of June 2021 Fluoxetine 20mg capsules and fluoxetine 20mg/5ml oral...
Medicine Supply Notification: Dalacin® (clindamycin) 2% vaginal cream
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Dalacin® (clindamycin) 2% vaginal cream MSN/2021/030 Tier 2 – medium impact Date of issue: 14/06/2021 Dalacin® (clindamycin) 2% vaginal cream is out of stock until w/c 6th September 2021. Alternative topical preparations are available The DHSC Medicine Supply Team provide...
Medicine Supply Notification: Diamorphine hydrochloride powder for reconstitution and injection 5mg and 10mg ampoules – Update
Update: (14/06/2021) 5mg out of stock until late June 2021 10mg out of stock until early July 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Diamorphine hydrochloride powder for reconstitution and injection 5mg and 10mg ampoules MSN/2021/021 Tier 2 – medium impact Date of issue: 09/04/2021 There...
Contractor Notice: Expiry of SSP012 for Estradot® 75 microgram patches
The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 75 microgram patches is now available to meet normal demand. As a result the Serious Shortage Protocol, SSP012 for Estradot® 75 microgram patches expires at 23.59pm on Friday 11 June 2021. After this date, any prescriptions for Estradot® 75 microgram patches must be...
Pharmacy teams: opportunity to join the PPE portal engagement panel
The Department of Health and Social Care (DHSC) is continuing its work to get feedback from the users of COVID-19 personal protective equipment (PPE) provided via the Government’s PPE portal. DHSC has already established a Pharmacy PPE engagement panel to gather feedback from pharmacy contractors and their teams on the quality and quantity of PPE...
Reminder: Deadline approaching for completion of the PQS Part 2 2020/21 work
Community pharmacy contractors are reminded that the deadline for completing the Pharmacy Quality Scheme (PQS) Part 2 2020/21 work is 30th June 2021. NHS England and NHS Improvement (NHSE&I) and the Department of Health and Social Care agreed to PSNC’s request for more flexible timings for completion of the PQS work in December last year. This means...
PSNC and MPs continue to highlight the value of pharmacy
PSNC is continuing its work to demonstrate the value of pharmacy to MPs. Recently there has been further recognition from MPs for all the work community pharmacies are doing to support patients and the wider NHS, as well as the pressures facing the pharmacy workforce. Minister confirms over five million COVID-19 vaccinations administered by pharmacy...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
Researchers develop COVID-19 antibody test to detect new variants
New antibody tests can detect if an individual has been exposed to COVID-19 variants, including Alpha and Delta variants
Lilly plans head-to-head migraine study comparing Emgality with Nurtec ODT
The primary endpoint of the study is a 50% reduction in monthly migraine headache days
Study demonstrates safety and efficacy of co-administering COVID-19 and flu vaccines
Study co-administered Novavax's COVID-19 vaccine alongside Seqirus' flu vaccines
Exscientia expands translational capabilities with Allcyte acquisition
Allcyte specialises in artificial intelligence (AI) based precision medicine
Biogen’s inherited eye disease gene therapy misses the mark in late-stage trial
Gene therapy was being evaluated for the treatment of the rare eye disease choroideremia
Imbruvica/Venclyxto tops Gazyva plus chemo in first-line CLL/SLL
Imbruvica treatment regimen demonstrated superior progression-free survival compared to Gazyva combo
AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant
New real world data from PHE shows vaccines can protect against hospitalisation caused by variant
Novavax’s COVID-19 vaccine shows 90% efficacy in Phase III
Jab was also found to be 100% effective at preventing moderate to severe COVID-19
Opdivo plus Yervoy scores NICE backing for certain bowel cancer patients
Immunotherapy combo approved for the treatment of advanced bowel cancer patients with rare MSI-H/dMMR mutations
Vertex, CRISPR Therapeutics’ blood disorder gene therapy shows more promise
CTX001 is being evaluated as a one-time treatment for transfusion dependent beta thalassemia and sickle cell disease
NICE to reassess Kyowa Kirin’s Poteligeo
An appeal lodged by the company and various charities has been upheld by an independent appeal panel
UK to donate 100 million surplus COVID-19 vaccine doses
Gov’t will donate five million of the surplus doses by the end of September
New hybrid healthcare agency Stirred launches
Stirred has been launched this week by former senior Pegasus colleagues Jo Spadaccino and Stuart Hehir
Novartis' oral therapy iptacopan shows promise in PNH
Majority of patients were transfusion-free through 12 weeks of study, according to the new data
Modus Therapeutics partners with Imperial College London on malaria drug
Collaboration will research the effects of Modus' drug sevuparin in patients with severe malaria
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/